GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IntriCon Corp (NAS:IIN) » Definitions » Revenue

IntriCon (IntriCon) Revenue : $126.5 Mil (TTM As of Mar. 2022)


View and export this data going back to 1968. Start your Free Trial

What is IntriCon Revenue?

IntriCon's revenue for the three months ended in Mar. 2022 was $33.1 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2022 was $126.5 Mil. IntriCon's Revenue per Share for the three months ended in Mar. 2022 was $3.57. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2022 was $13.64.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


IntriCon Revenue Historical Data

The historical data trend for IntriCon's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntriCon Revenue Chart

IntriCon Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 86.95 113.95 113.49 102.77 125.21

IntriCon Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.77 30.22 31.05 32.17 33.06

Competitive Comparison of IntriCon's Revenue

For the Medical Instruments & Supplies subindustry, IntriCon's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IntriCon's Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IntriCon's Revenue distribution charts can be found below:

* The bar in red indicates where IntriCon's Revenue falls into.



IntriCon Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $126.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IntriCon  (NAS:IIN) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


IntriCon Revenue Related Terms

Thank you for viewing the detailed overview of IntriCon's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


IntriCon (IntriCon) Business Description

Traded in Other Exchanges
N/A
Address
1260 Red Fox Road, Arden Hills, MN, USA, 55112
IntriCon Corp is an international company and joint development manufacturer (JDM) of micromedical components, sub-assemblies and final devices. The company serves as a JDM partner to medical device original equipment manufacturers by designing, developing, engineering, manufacturing, packaging and distributing micromedical products for high growth markets, such as diabetes, peripheral vascular, interventional pulmonology, electrophysiology and hearing healthcare. It manufactures microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components and complete body-worn devices for leading and emerging medical device manufacturers.
Executives
Annalee Lutgen officer: Interim CFO C/O INTRICON CORPORATION 1260 RED FOX ROAD ARDEN HILLS MN 55112
Michael Geraci officer: Vice President, Sales 1260 RED FOX ROAD ARDEN HILLS MN 55112
Dennis Gonsior officer: Vice Pres., Global Operations 1260 RED FOX ROAD ARDEN HILLS MN 55112
Kathleen P. Pepski director 3100 EAST HENNEPIN AVENUE, MINNEAPOLIS MN 55413
Ellen Scipta officer: CFO C/O INTRICON CORPORATION, 1260 RED FOX ROAD, ARDEN HILLS MN 55112
Heather D. Rider director C/O INOGEN, INC., 326 BOLLAY DRIVE, GOLETA CA 93117
Raymond Huggenberger director 326 BOLLAY DRIVE, GOLETA CA 93117
Greg Gruenhagen officer: VP, Corp. Qlty. & Reg. Affairs C/O INTRICON CORPORATION 1260 RED FOX ROAD ARDEN HILLS MN 55112
Philip Irving Smith director 4503 BROWNDALE AVENUE, EDINA MN 55424
Scott Longval officer: Chief Financial Officer 1260 RED FOX ROAD ARDEN HILLS MN 55112
Mark Stephen Gorder director, officer: President & CEO 1260 RED FOX RD ARDEN HILLS MN 55112
Steven Binnix officer: Vice President-RTI Electronics 1260 RED FOX ROAD ARDEN HILLS MN 55112
Michael J Mckenna director 8650 S OCEAN DRIVE APT 701 JENSEN BEACH FL 34957
Robert N Masucci director 1406 GRASSHOPPER LANE GWYNEDD VALLEY PA 19437
Philip N Seamon director 1260 RED FOX ROAD ARDEN HILLS MN 55112